Diosmin and regulatory quality: Bordas’ success at CPHI Milan
CPHI Milan has established itself as the global meeting place par excellence for the pharmaceutical sector, a highly demanding environment where ingredient quality, industrial capacity and compliance with regulatory frameworks are non-negotiable. For us at Bordas, participating in this event is a key opportunity to highlight our extensive experience as a manufacturer specialised in citrus flavonoids and demonstrate our ability to meet, with full guarantees, the complex needs of API manufacturers and pharmaceutical companies.
Pharmaceutical excellence and innovation at CPHI Milan
Our presence at CPHI has reaffirmed that technical aspects such as ingredient specifications, the rigour of regulatory documentation, batch-to-batch consistency and supply chain reliability are, today more than ever, the pillars upon which trust in the healthcare industry is built.
During the event, we highlighted our main specialities, designed to exceed the most rigorous standards:
Diosmin and MPFF: The core of our proposal
Diosmin, micronised diosmin and micronised purified flavonoid fraction (MPFF) form the heart of our offering for the pharmaceutical market. In this field, our position as one of the leading European producers makes the difference.
We know that for micronised diosmin and MPFF, particle size is critical. Our ability to provide ingredients with technical characteristics defined down to the millimetre and tailored to the demands of each formulation makes us a key strategic partner.
Hesperidin and NHDC: Technological allies in formulation
We complete our flavonoid portfolio with hesperidin (in standard and micronised presentations) to respond to diverse technical needs.
On the other hand, neohesperidin DC (NHDC) shines for its technological function. Thanks to its potent sweetening capacity and flavour-modulating effect, it acts almost as an excipient, helping to mask the bitterness of certain active ingredients and radically improving the organoleptic characteristics of the final medicine or nutraceutical.
Quality, traceability and industrial capacity
At CPHI Milan, it has become clear that a great ingredient requires robust backing behind it:
- Regulatory documentation and compliance: Having GMP certifications and the availability of critical documentation such as CEP and ASMF is essential to support the confidence of medicine manufacturers.
- A century of experience and reliability: With over 100 years of experience in citrus-derived ingredients, Bordas offers absolute control over the traceability of raw materials.
- Consistency and supply: Our integrated value chain guarantees continuity of supply and flawless batch-to-batch consistency, minimising industrial risks for our clients.
Nutraceuticals and flavour modulation
Although our focus at CPHI has been markedly pharmaceutical, the conversations allowed us to explore complementary applications of exceptionally high value:
- CITRONEO® and NAROMINE®: Advanced solutions for flavour modulation and bitterness masking in complex formulations.
- NAROXIN® and CITRIFLAV®: Ingredients that harness the natural antioxidant capacity of citrus flavonoids.
- Digestive health: We continue to investigate the prebiotic potential and effects on gut microbiota of our ingredients, delivering significant added value to companies focused on nutraceuticals and food supplements.
A special thank you
This resounding success would not have been possible without the ecosystem that surrounds us. We would like to thank all the clients and pharmaceutical companies that visited our stand to seek new solutions; our strategic partners, for their unconditional support; and very specially the great team at Bordas, whose rigour, knowledge and industrial passion allow us to continue leading this specialised market.
